Core Laboratories Inc
(CLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 114,095 | 131,508 | 111,315 | 82,662 | 31,211 |
| Depreciation Amortization | 23,818 | 25,743 | 21,197 | 17,693 | 17,061 |
| Income taxes - deferred | 25,636 | -9,596 | 166 | 8,063 | 81 |
| Accounts receivable | 9,990 | -5,025 | -24,721 | -14,803 | -5,331 |
| Accounts payable and accrued liabilities | -8,579 | 1,454 | 2,173 | 6,254 | 3,926 |
| Other Working Capital | -1,977 | -12,340 | -17,200 | 6,826 | 8,069 |
| Other Operating Activity | 18,890 | 23,463 | 32,765 | 13,610 | 19,761 |
| Operating Cash Flow | $181,873 | $155,207 | $125,695 | $120,305 | $74,778 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,705 | -27,152 | -10,038 | -21,701 | -15,165 |
| Net Acquisitions | N/A | -11,536 | -7,338 | N/A | N/A |
| Purchase Sale Intangibles | -240 | -354 | -317 | -266 | -103 |
| Other Investing Activity | -1,835 | -2,420 | -2,599 | -1,894 | -1,199 |
| Investing Cash Flow | $-18,540 | $-41,108 | $-19,975 | $-23,595 | $-16,364 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 5,000 | 4,516 | 342,000 | 82,000 |
| Debt Repayment | 0 | -61,397 | -4,253 | -131,504 | -108,982 |
| Common Stock Issued | 408 | 1,167 | 18,454 | 71,353 | 8,215 |
| Common Stock Repurchased | -9,389 | -31,740 | -181,812 | -251,088 | -41,446 |
| Dividend Paid | -26,675 | -27,645 | N/A | N/A | N/A |
| Other Financing Activity | 17,230 | 11,037 | 28,769 | -86,991 | -488 |
| Financing Cash Flow | $-18,426 | $-103,578 | $-134,326 | $-56,230 | $-60,701 |
| Beginning Cash Position | 36,138 | 25,617 | 54,223 | 13,743 | 16,030 |
| End Cash Position | 181,045 | 36,138 | 25,617 | 54,223 | 13,743 |
| Net Cash Flow | $144,907 | $10,521 | $-28,606 | $40,480 | $-2,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | 181,873 | 155,207 | 125,695 | 120,305 | 74,778 |
| Capital Expenditure | -17,289 | -30,950 | -23,827 | -24,415 | -19,095 |
| Free Cash Flow | 164,584 | 124,257 | 101,868 | 95,890 | 55,683 |